Kathmere Capital Management’s Chemours CC Stock Holding History

Kathmere Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-120	Closed	-$3K	–	171
2020 Q4	$3K	Hold	120	–	–	﹤0.01%	364
2020 Q3	$3K	Buy	+120	New	+$2.32K	﹤0.01%	342

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Kathmere Capital Management's CC Position: Q1 2021 in Review

Kathmere Capital Management sold out of Chemours (CC) in Q1 2021, closing a stake of 120 shares — an estimated $3K sold.

Kathmere Capital Management first reported a position in CC in Q3 2020 and held it in 2 quarters. The position peaked at $3K in Q4 2020. 431 funds tracked by Wall St. Rank hold CC as of Q1 2021.

Kathmere Capital Management reported no remaining Chemours position as of Q1 2021 after selling out during the quarter.
Kathmere Capital Management sold 120 Chemours shares in Q1 2021, an estimated $3K.
Kathmere Capital Management first reported a position in Chemours in Q3 2020 and held it in 2 quarters.
Kathmere Capital Management's Chemours position peaked at $3K in Q4 2020.
431 funds tracked by Wall St. Rank held Chemours as of Q1 2021.

Based on Kathmere Capital Management's 13F filing for Q1 2021, filed 7 May 2021.